A.-E. Roske

1.8k citations
16 papers · 1.6k · h-index 8

Impact in

    • Histone Deacetylase Inhibitors Research
    • Protein Degradation and Inhibitors
    • Epigenetics and DNA Methylation
    • Nuclear Structure and Function
    • Ubiquitin and proteasome pathways
    • Cancer-related gene regulation
    • RNA modifications and cancer
  • Oncology top 10%
    • Peptidase Inhibition and Analysis

Papers in

    • Histone Deacetylase Inhibitors Research 4
    • RNA modifications and cancer 1
    • Liver Disease Diagnosis and Treatment 4

A.-E. Roske

16 papers receiving 1.5k citations

Peers

A.-E. Roske
Comparison fields: 5 of 72
  • Molecular Biology 1.3k
  • Oncology 343
  • Cancer Research 141
  • Geriatrics and Gerontology 20
  • Hematology 54
Replace Ann‐Christin Buckendahl with:
Ann‐Christin Buckendahl Germany
Hengrui Zhu China
Sonia Alix United Kingdom
Jun-Ying Zhou United States
Maria Serena Roca Italy
Brian B. Lee United States
Mingrui Zhu China
Daniel Iglesias‐Serret Spain
Vladimir Cmiljanović Switzerland
Yves Communal France
A.-E. Roske relative to Ann‐Christin Buckendahl Germany Ann‐Christin Buckendahl's profile →
Citations per field
00.5×1.5×2.2×
Ann‐Christin Buckendahl · 1×
Citations per year

Countries citing papers authored by A.-E. Roske

Since Specialization
Citations

This map shows the geographic impact of A.-E. Roske's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.-E. Roske with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.-E. Roske more than expected).

Fields of papers citing papers by A.-E. Roske

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.-E. Roske. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.-E. Roske. The network helps show where A.-E. Roske may publish in the future.

Co-authors

The 25 scholars most cited alongside A.-E. Roske, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A.-E. Roske Line = papers co-authored together A.-E. Roske links everyone, so they are left out of the graph.

All Works

16 of 16 papers shown
#Work
1 2008421
2 2008328
3 2008319
4 2008195
5 2008151
6 200868
7 200934
8 200925
9 20014
10
[NF-kappaB subunit p65/RelA expression in ovarian carcinoma: prognostic impact and link to COX-2 overexpression].
20074
11 19971
12 19971
13 19981
14 19981
15 19981
16 19981

About A.-E. Roske

A.-E. Roske is a scholar working on Molecular Biology, Epidemiology, Cancer Research, Physiology and Clinical Biochemistry, having authored 16 papers that have together received 1.6k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Clinical Nutrition and Gastroenterology (1 paper), RNA modifications and cancer (1 paper), Liver Disease and Transplantation (1 paper), Lung Cancer Research Studies (1 paper), Optical Coherence Tomography Applications (1 paper) and NF-κB Signaling Pathways (1 paper). The work is most often cited by research in Molecular Biology (1.3k citations), Oncology (343 citations), Cancer Research (141 citations), Geriatrics and Gerontology (20 citations) and Hematology (54 citations). A.-E. Roske has collaborated with scholars based in Germany, Switzerland and Denmark. Frequent co-authors include Wilko Weichert, Carsten Denkert, Manfred Dietel, Volker Gekeler, Thomas L. Beckers, Silvia Niesporek, Aurelia Noske, Ann‐Christin Buckendahl, Carsten Stephan and Klaus Jung. Their work appears in journals such as Clinical Nutrition, Gastroenterology, International Journal of Gynecological Pathology, Journal of Cancer Research and Clinical Oncology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact